News
Before, we told you to delete your data because 23andMe was about to be sold. Now, a buyer has been announced, and they’re ...
The price tag of this acquisition suggests that the value of genetic data is declining. Back in 2018, the drug company GSK ...
Regeneron Pharmaceuticals enters into asset purchase agreement to acquire 23andMe for $256 million: Tarrytown, New York Wednesday, May 21, 2025, 13:00 Hrs [IST] Regeneron Pharmace ...
22h
Tampa Free Press on MSNFDA Overhauls COVID-19 Vaccine Approval Process, Shifting Focus To High-Risk IndividualsThe U.S. Food and Drug Administration (FDA) is set to significantly alter its approach to approving COVID-19 vaccines, a move that will primarily limit future vaccine recommendations to older ...
Regeneron has been busy, with two health tech deals announced this week: One is about genetic data and one about AI. Both of ...
The story of chronic itch and its impact on quality of life is one dermatologists have heard often. Until recently, treatment ...
A new report by FutureWise Research highlights a powerful trend in modern medicine: as awareness and innovation rise, hope ...
The agency will now require randomized, controlled data before approving new COVID shots for healthy children and adults, ...
Want to study abroad but worried about clearing IELTS? Great news! In this video, we reveal 5 countries where Indian students can study without IELTS in 2025. From Germany to Malaysia, explore top ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results